Safety and pharmacokinetics of motesanib in combination with gemcitabine for the treatment of patients with solid tumours

Tekijä Price, T J, Lipton, L, McGreivy, J, McCoy, S, Sun, Y-N, Rosenthal, M A
Julkaistu 2008

Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia

Tekijä Byrd, J.C., Brown, J.R., O’Brien, S., Barrientos, J.C., Kay, N.E., Reddy, N.M., Coutre, S., Tam, C.S., Mulligan, S.P., Jaeger, U., Devereux, S., Barr, P.M., Furman, R.R., Kipps, T.J., Cymbalista, F., Pocock, C., Thornton, P., Caligaris-Cappio, F., Robak, T., Delgado, J., Schuster, S.J., Montillo, M., Schuh, A., de Vos, S., Gill, D., Bloor, A., Dearden, C., Moreno, C., Jones, J.J., Chu, A.D., Fardis, M., McGreivy, J., Clow, F., James, D.F., Hillmen, P.
Julkaistu 2014